Literature DB >> 18777117

Association between Val/Leu(247) polymorphism of apolipoprotein H and cerebral infarction in a Chinese population.

Jian Xia1, Mei Yuan, Hong-wei Xu, Le Zhang, Xiao-ping Du, Yun-hai Liu, Qi-dong Yang.   

Abstract

BACKGROUND: Antiphospholipid antibodies (aPL) are considered to be a cause of an acquired hypercoagulable state leading to cerebral infarction (CI). Apolipoprtein H (apoH) is an important target antigen for aPL and thus apoH polymorphisms may influence aPL production and the development of CI. The purpose of this study was to identify associations between the Val/Leu(247) polymorphism of apoH gene and CI in a Chinese cohort.
METHODS: This study comprised 130 CI patients and 100 healthy control subjects. Polymorphism assignment was determined by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) technique and DNA sequencing. The presence of aPL was detected by ELISA utilizing irradiated ELISA plates.
RESULTS: Our results demonstrated an association between the Val/Leu(247) polymorphism of apoH gene and aPL in CI patients. The frequency of V allele was significantly higher in aPL-positive CI patients compared with control group (chi(2) = 6.864, P < 0.05). VL genotype frequency was also significantly higher in aPL-positive CI group compared with control group (chi(2) = 13.879, P < 0.05) and aPL-negative CI group (chi(2) = 5.567, P < 0.05).
CONCLUSIONS: The Val(247) allele of apoH gene is significantly associated with the presence of aPL in Chinese patients with CI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18777117     DOI: 10.1007/s11239-008-0267-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  27 in total

1.  [Expression of beta 2 glycoprotein I, the major target antigen for anti-cardiolipin antibodies, in human endothelium].

Authors:  Y Miyoshi
Journal:  Hokkaido Igaku Zasshi       Date:  2001-09

2.  Molecular basis of the apolipoprotein H (beta 2-glycoprotein I) protein polymorphism.

Authors:  D K Sanghera; T Kristensen; R F Hamman; M I Kamboh
Journal:  Hum Genet       Date:  1997-07       Impact factor: 4.132

Review 3.  Lipids and stroke: the opportunity of lipid-lowering treatment.

Authors:  José Vivancos-Mora; Antonio C Gil-Núñez
Journal:  Cerebrovasc Dis       Date:  2005-12-02       Impact factor: 2.762

Review 4.  Genetic aspects of the hemostatic system in cerebrovascular disease.

Authors:  A J Catto
Journal:  Neurology       Date:  2001       Impact factor: 9.910

Review 5.  Advances in the genetics of cerebrovascular disease and stroke.

Authors:  G J Hademenos; M J Alberts; I Awad; M Mayberg; T Shepard; A Jagoda; R E Latchaw; H W Todd; K Viste; R Starke; M S Girgus; J Marler; M Emr; N Hart
Journal:  Neurology       Date:  2001-04-24       Impact factor: 9.910

6.  A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I.

Authors:  Haider Mehdi; Susan Manzi; Purnima Desai; Qi Chen; Cara Nestlerode; Franklin Bontempo; Stephen C Strom; Reza Zarnegar; M Ilyas Kamboh
Journal:  Eur J Biochem       Date:  2003-01

7.  Association between beta2-glycoprotein I gene polymorphisms and pediatric SLE and antiphospholipid antibodies.

Authors:  E von Scheven; M E Elder
Journal:  Lupus       Date:  2005       Impact factor: 2.911

8.  Valine/valine genotype at position 247 of the beta2-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies.

Authors:  G Aleph Prieto; Antonio R Cabral; Martín Zapata-Zuñiga; Abraham J Simón; Antonio R Villa; Donato Alarcón-Segovia; Javier Cabiedes
Journal:  Arthritis Rheum       Date:  2003-02

9.  Single nucleotide polymorphisms in the coding region of the apolipoprotein H (beta2-glycoprotein I) gene and their correlation with the protein polymorphism, anti-beta2glycoprotein I antibodies and cardiolipin binding: description of novel haplotypes and their evolution.

Authors:  M Ilyas Kamboh; Dharambir K Sanghera; Haider Mehdi; Cara S Nestlerode; Qi Chen; Osama Khalifa; Asma Naqvi; Susan Manzi; Clareann H Bunker
Journal:  Ann Hum Genet       Date:  2004-07       Impact factor: 1.670

10.  Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.

Authors:  E Matsuura; Y Igarashi; T Yasuda; D A Triplett; T Koike
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.